Desk›Healthcare› Metropolis Healthcare Ltd
Metropolis Healthcare Ltd
BSE 542650 · NSE METROPOLIS · ISIN INE112L01020 · Group A · Active
Healthcare › Healthcare › Healthcare Services › Healthcare Service Provider
₹588.20
+1.98%
BSE close, 28 August 2026
₹12,197.44 cr
20.7 cr shares · Small cap
₹6,227.44 cr
as published
70.7× · 11.03×
EPS ₹8.32 · BV ₹53.33
1,365.47 / 157.48
₹ cr, as filed
33
9 selected · 27%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -3.4% |
|---|---|
| Against 52-week low | +42.4% |
| Day change | +1.98% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹8.32 |
|---|---|
| Price / earnings | 70.70× |
| Price / book | 11.03× |
| Book value — derived, price ÷ P/B | ₹53.33 |
| Return on equity | 15.60% |
| Operating margin | 26.58% |
| Net margin | 13.59% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 15.60%
- ROE as published
- 15.60%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 372.28 | 50.58 | 2.44 | 26.58% | 13.59% |
| Mar-26 · Q | 352.03 | 43.24 | 2.09 | 28.11% | 12.28% |
| FY25-26 | 1,365.47 | 157.48 | 7.60 | 25.38% | 11.53% |
Quarter on quarter
- Revenue, quarter on quarter
- +5.8%
- Net profit, quarter on quarter
- +17.0%
- Operating margin, quarter on quarter
- -153 bps
Disclosure profile 33 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Concall Transcript | 2 |
| Investor Presentation | 2 |
| Restructuring | 2 |
| Board Outcome | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 9 |
| Procedural | |
| Analyst / Investor Meet | 4 |
| General | 4 |
| AGM / EGM | 3 |
| Newspaper Publication | 3 |
| SAST | 3 |
| ESOP Allotment | 2 |
| Annual Report | 1 |
| BRSR | 1 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Trading Window | 1 |
| Procedural sub-total | 24 |
| Total | 33 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
33 filings · 9 selected · busiest 2026-08-04
Filing rhythm · the twelve most recent
2026-08-202026-10-06
SelectedProcedural
Filings
33 in the window · 4 earlier on record
-
6 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
5 October 2026 ·
-
28 September 2026 ·
Closure of Trading Window
Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
9 September 2026 ·
Allotment of ESOP / ESPS
Allotment of 66,312 equity shares under the Metropolis- Restrictive Stock Unit Plan, 2020
Company Update / Allotment of ESOP / ESPS View filing →
-
7 September 2026 ·
Restructuring
Disclosure under Regulation 30 of SEBI Listing Regulations
Company Update / Restructuring View filing →
-
7 September 2026 ·
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Franklin Templeton Mutual Fund
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
2 September 2026 ·
Earnings Call Transcript
Transcript of Investors & Analyst Meet held on Thursday, August 27, 2026
Company Update / Earnings Call Transcript View filing →
-
27 August 2026 ·
Analyst / Investor Meet - Outcome
Audio recording of the Investors & Analyst Meet
Company Update / Analyst / Investor Meet View filing →
-
27 August 2026 ·
Disclosure Under Regulation 30 Of SEBI Listing Regulations
Disclosure under Regulation 30 of SEBI Listing Regulations
Company Update / General View filing →
-
27 August 2026 ·
-
20 August 2026 ·
Restructuring
Disclosure under Regulation 30 of SEBI Listing Regulations
Company Update / Restructuring View filing →
-
20 August 2026 ·
Analyst / Investor Meet - Intimation
Schedule of Analyst / Institutional Investor Meeting
Company Update / Analyst / Investor Meet View filing →
-
19 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizer's Report for the 26th Annual General Meeting
AGM/EGM / AGM View filing →
-
18 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 26th Annual General Meeting of the Company
AGM/EGM / AGM View filing →
-
13 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Metz Advisory LLP & PACs
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
13 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Duru Shah Family Trust & PACs
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
10 August 2026 ·
Earnings Call Transcript
Transcript of Q1 FY27 earnings conference call held on Wednesday, August 05, 2026
Company Update / Earnings Call Transcript View filing →
-
5 August 2026 ·
Analyst / Investor Meet - Outcome
Link of audio recording of the earnings conference call held on August 05, 2026
Company Update / Analyst / Investor Meet View filing →
-
5 August 2026 ·
-
4 August 2026 ·
Investor Presentation
Investor Presentation for the quarter ended June 30, 2026
Company Update / Investor Presentation View filing →
-
4 August 2026 ·
Press Release / Media Release
Press Release
Company Update / Press Release / Media Release View filing →
-
4 August 2026 ·
Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2026
Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026
Result / Financial Results View filing →
-
4 August 2026 ·
Board Meeting Outcome for The Meeting Held Today (August 04, 2026)
Outcome of Board Meeting
Board Meeting / Outcome of Board Meeting View filing →
-
4 August 2026 ·
-
4 August 2026 ·
Allotment of ESOP / ESPS
Allotment of 18,700 equity shares under the Metropolis-Restrictive Stock Unit Plan, 2020
Company Update / Allotment of ESOP / ESPS View filing →
-
28 July 2026 ·
Analyst / Investor Meet - Intimation
The Company will participate in the Q1FY27 earnings conference call (i.e. post earnings/quarterly call), organized by JM Financial Institutional Securities Limited on Wednesday, August ....
Company Update / Analyst / Investor Meet View filing →
-
28 July 2026 ·
Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2026
Metropolis Healthcare Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve the un-audited standalone ....
Board Meeting / Board Meeting View filing →
-
28 July 2026 ·
-
27 July 2026 ·
Letter To Shareholders Containing Weblink Of Annual Report For The Financial Year 2025-26 And 26Th Annual General Meeting
Letter to Shareholders containing weblink of Annual Report for the financial year 2025-26 and 26th Annual General Meeting
Company Update / General View filing →
-
27 July 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report for the financial year 2025-26
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
27 July 2026 ·
Notice Of The 26Th Annual General Meeting For The Financial Year 2025-26
Notice of the 26th Annual General Meeting for the financial year 2025-26 to be held on August 18, 2026
AGM/EGM / AGM View filing →
-
27 July 2026 ·
Reg. 34 (1) Annual Report.
Annual Report for the financial year 2025-26
Others / Reg. 34 (1) Annual Report View filing →
-
24 July 2026 ·
RSS feed for Metropolis Healthcare Ltd · the 50 most recent filings